BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38070719)

  • 1. Depletion of macrophages deteriorates BrONJ-like lesions in mice. Bone. 2023 Dec;177:116899.
    Pazianas M
    Bone; 2024 Apr; 181():116988. PubMed ID: 38070719
    [No Abstract]   [Full Text] [Related]  

  • 2. Depletion of macrophages deteriorates bisphosphonate-related osteonecrosis of the jaw-like lesions in mice.
    Kozutsumi R; Kuroshima S; Al-Omari FA; Hayano H; Nakajima K; Kakehashi H; Sawase T
    Bone; 2023 Dec; 177():116899. PubMed ID: 37708951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
    Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
    Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice.
    Kuroshima S; Nakajima K; Sasaki M; I T; Sumita Y; Asahara T; Asahina I; Sawase T
    Stem Cell Res Ther; 2019 Jul; 10(1):209. PubMed ID: 31311585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of Noncultured Stromal Vascular Fraction Cells of Adipose Tissue Ameliorates Osteonecrosis of the Jaw-Like Lesions in Mice.
    Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
    J Bone Miner Res; 2018 Jan; 33(1):154-166. PubMed ID: 28902422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice.
    Hayano H; Kuroshima S; Sasaki M; Tamaki S; Inoue M; Ishisaki A; Sawase T
    Bone; 2020 Jun; 135():115308. PubMed ID: 32142911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw.
    Zhu W; Xu R; Du J; Fu Y; Li S; Zhang P; Liu L; Jiang H
    FASEB J; 2019 Apr; 33(4):5208-5219. PubMed ID: 30624969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose-derived stem cells prevent the onset of bisphosphonate-related osteonecrosis of the jaw through transforming growth factor β-1-mediated gingival wound healing.
    Zang X; He L; Zhao L; He Y; Xiao E; Zhang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):169. PubMed ID: 31196208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wound healing protein profiles in the postoperative exudate of bisphosphonate-related osteonecrosis of mandible.
    Kim SM; Eo MY; Cho YJ; Kim YS; Lee SK
    Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3485-3495. PubMed ID: 28647850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients' Gingiva.
    Li M; Wang J; Yu Y; Zhou Y; Shi Y; Zhang W; Son G; Ge J; Zhao J; Yang C; Wang S
    Stem Cell Rev Rep; 2022 Jan; 18(1):378-394. PubMed ID: 34553308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis.
    Aoki K; Matsunaga S; Ito S; Shibahara T; Nomura T; Matsuzaki H; Abe S; Yamaguchi A
    J Bone Miner Metab; 2021 Sep; 39(5):737-747. PubMed ID: 33830351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model.
    Kaibuchi N; Iwata T; Yamato M; Okano T; Ando T
    Acta Biomater; 2016 Sep; 42():400-410. PubMed ID: 27326918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link?
    De Ceulaer J; Tacconelli E; Vandecasteele SJ
    Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1873-80. PubMed ID: 24880820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis.
    Wehrhan F; Moebius P; Amann K; Ries J; Preidl R; Neukam FW; Weber M
    J Craniomaxillofac Surg; 2017 Jun; 45(6):944-953. PubMed ID: 28365078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws.
    Zhang Q; Atsuta I; Liu S; Chen C; Shi S; Shi S; Le AD
    Clin Cancer Res; 2013 Jun; 19(12):3176-88. PubMed ID: 23616636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases.
    Hoefert S; Schmitz I; Weichert F; Gaspar M; Eufinger H
    Clin Oral Investig; 2015 Mar; 19(2):497-508. PubMed ID: 24957986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF-BB exhibited therapeutic effects on rat model of bisphosphonate-related osteonecrosis of the jaw by enhancing angiogenesis and osteogenesis.
    Gao SY; Lin RB; Huang SH; Liang YJ; Li X; Zhang SE; Ouyang DQ; Li K; Zheng GS; Liao GQ
    Bone; 2021 Mar; 144():115117. PubMed ID: 31676407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
    Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
    Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.